BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 17673914)

  • 1. Management of patients with upper urinary tract transitional cell carcinoma.
    Raman JD; Scherr DS
    Nat Clin Pract Urol; 2007 Aug; 4(8):432-43. PubMed ID: 17673914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
    Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
    Urology; 2008 Apr; 71(4):713-7. PubMed ID: 18267338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments.
    Sanderson KM; Rouprêt M
    BJU Int; 2007 Jul; 100(1):11-6. PubMed ID: 17428248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract.
    Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
    BJU Int; 2008 Nov; 102(9):1107-10. PubMed ID: 18522631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
    Chen GL; Bagley DH
    J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder tumor recurrence after primary surgery for transitional cell carcinoma of the upper urinary tract.
    Oehlschläger S; Baldauf A; Wiessner D; Gellrich J; Hakenberg OW; Wirth MP
    Urol Int; 2004; 73(3):209-11. PubMed ID: 15539838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Walton TJ; Sherwood BT; Parkinson RJ; Obakponovwe O; Thomas SA; Taylor MC; England RC; Lemberger RJ
    J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
    Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
    Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers.
    Novara G; De Marco V; Dalpiaz O; Galfano A; Bouygues V; Gardiman M; Martignoni G; Patard JJ; Artibani W; Ficarra V
    Int J Urol; 2009 Feb; 16(2):187-91. PubMed ID: 19054165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of endoscopy in the management of upper urinary tract tumors].
    Roupret M; Cussenot O; Chartier-Kastler E; Thibault P; Richard F; Conort P; Traxer O
    Prog Urol; 2006 Nov; 16(5):537-41. PubMed ID: 17175946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S; Mita K; Shigeta M; Usui T
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imperative indications for conservative management of upper tract transitional cell carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Elliott DS; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic treatment of upper tract transitional cell carcinoma.
    Soderdahl DW; Fabrizio MD; Rahman NU; Jarrett TW; Bagley DH
    Urol Oncol; 2005; 23(2):114-22. PubMed ID: 15869996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic distal ureterectomy and anastomosis for management of low-risk upper urinary tract transitional cell carcinoma: preliminary results.
    Rouprêt M; Harmon JD; Sanderson KM; Barret E; Cathelineau X; Vallancien G; Rozet F
    BJU Int; 2007 Mar; 99(3):623-7. PubMed ID: 17407517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of transitional cell carcinoma (TCC) in a European regional renal transplant population.
    Rogers A; Ng JK; Glendinning J; Rix D
    BJU Int; 2012 Jul; 110(2 Pt 2):E34-40. PubMed ID: 22243691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ureteroscopic resection of upper-tract transitional-cell carcinoma.
    Ho KL; Chow GK
    J Endourol; 2005 Sep; 19(7):841-8. PubMed ID: 16190841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic management of upper tract urothelial tumors.
    Stoller ML; Gentle DL; McDonald MW; Reese JH; Tacker JR; Carroll PR; Best C
    Tech Urol; 1997; 3(3):152-7. PubMed ID: 9422447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Office-based surveillance ureteroscopy after endoscopic treatment of transitional cell carcinoma: technique and clinical outcome.
    Reisiger K; Hruby G; Clayman RV; Landman J
    Urology; 2007 Aug; 70(2):263-6. PubMed ID: 17826486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.